The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Repidose Ready Pulse

1250 mg/tablet Bolus

Intervet Ireland LimitedVPA10996/254/001

Main Information

Trade NameRepidose Ready Pulse
Active SubstancesOxfendazole
Strength1250 mg/tablet
Dosage FormBolus
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/254/001

Group Information

ATC CodeQP52AC02 oxfendazole
Therapeutic ClassEndoparasiticide


Licence Issued01/10/1999
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back